3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Stomatitis
2
Retinoblastoma
2
Keratosis, Actinic
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Diseases
1
Peripheral Nervous System Diseases
1
Pelvic Pain
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Melanoma
1
Keratosis
1
Hyperthermia
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Desmoid Tumors
1
Colonic Neoplasms
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bowen's Disease
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Agnosia
1
Adenoma, Islet Cell
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Cyclophosphamide
6
Platinum
5
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Cryotherapy
×
1 year
×
Clear all
No trials found.